ARCHIVES

Drug Effectiveness Weakens After Three Years, Study Says

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

DeVita Considers Laetrile Tests

June 3, 1977

Vasectomy Doesn’t Increase Prostate Cancer Risk

July 26, 2002

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

November 12, 2004

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008

In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell

February 4, 1977